FDA Inspection 1249247 — Pawel Szalecki, M.D.
The FDA completed an inspection of Pawel Szalecki, M.D. on Jul 25, 2024 in Piaseczno. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 25, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Piaseczno (Poland)
Additional Details
Clinical Investigator (CI)